Annotation: The use of psychotropic medications in children: A British view

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 44, Issue 2, 2003, Pages 169-179

  Bramble, David ^a  

^a Telford/Wrekin Primary Care Trust   (United Kingdom)

Author keywords

Children's Mental health; Paediatric psychopharmacology; Prescribing practices; Psychiatric practice

Indexed keywords

ALIMEMAZINE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CHLORPROMAZINE; CLONIDINE; CLOZAPINE; DEXAMPHETAMINE; EQUASYM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LONG ACTING DRUG; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PROMETHAZINE; PSYCHOTROPIC AGENT; RISPERIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; UNINDEXED DRUG; VALPROIC ACID;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR THERAPY; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG INFORMATION; DRUG POTENTIATION; DRUG SAFETY; DRUG USE; ENURESIS; EXTRAPYRAMIDAL SYMPTOM; GENERAL PRACTITIONER; HUMAN; LEARNING DISORDER; LOW DRUG DOSE; MEDICAL PRACTICE; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL HEALTH CARE; METHODOLOGY; NOCTURNAL ENURESIS; PEDIATRICIAN; POSTGRADUATE EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QUESTIONNAIRE; REVIEW; SIDE EFFECT; SLEEP DISORDER; UNITED KINGDOM; ARTICLE; CHILD; CLINICAL PRACTICE; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; MEDICAL EDUCATION; PRESCHOOL CHILD; STATISTICS;

CHILD; CHILD PSYCHIATRY; CHILD, PRESCHOOL; EDUCATION, MEDICAL, GRADUATE; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; MENTAL DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PSYCHOTROPIC DRUGS;

EID: 0038530839     PISSN: 00219630     EISSN: None     Source Type: Journal    
DOI: 10.1111/1469-7610.00111     Document Type: Review

References (64)

1. Adams, S. (1991). Prescribing of psychotropic drugs to children and adolescents (letter). British Medicla Journal, 302, 217.
2. Bailey, V., Graham, P., & Boniface, D. (1978). How much child psychiatry does a general practitioner do? British Journal of Psychiatry, 13, 110-118.
3. Bain, D. (1981). Monitoring and prescription of psychotropic drugs. In R. Morry (Ed.), The Misuse of Psychotropic Drugs (pp. 70-92). London: Royal College of Physicians.
4. Berney, T., Kolvin, I., Bhate, S., Garside, R., Jeans, J., Kay, B., & Scarth, L. (1981). School phobia: A therapeutic trial of clomipramine and short-term outcome. British Journal of Psychiatry, 138, 110-118.
5. Boreus, L. (1983). The role of therapeutic drug monitoring in childhood. Pediatric Pharmacology, 3, 145-148.
6. Bramble, D. (1997). Psychostimulant prescription by British child psychiatrists. Child Psychology and Psychiatry Review, 2, 159-162.
7. Bramble, D. (2000). Psychostimulants and psychiatrists: The Trent adult psychiatry psychostimulant survey. Journal of Psychopharmacology, 14, 67-69.
8. Bramble, D., & Cosgrove, P. (2002). Parental assessments of the efficacy of risperidone in attention deficit hyperactivity disorder. Clinical Child Psychology and Psychiatry, 7, 225-233.
9. Bramble, D., & Dunkley, S. (1992). The use of antidepressants by British child psychiatrists. Psychiatric Bulletin, 16, 396-399.
10. British Association for Psychopharmacology. (1997). Child and learning disability psychopharmacology. BAP consensus statement. Journal of Psychopharmacology, 11, 291-294.
11. Broughton, R., Fleming, J., George, C., Hill, J., Kryger, M., Moldofsky, H., Montplaisir, J., Morehouse, R., Moscovitch, A., & Murphy, W. (1997). Randomised, double-blind, placebo controlled, crossover trial of modafinal in the treatment of excessive daytime sleepiness in narcolepsy. Neurology, 49, 444-451.
12. Conroy, S., Chonare, S., Impicciatore, P., Mohn, A., Arnell, H., Rane, A., Knoeppel, C., Seyberth, H., Pandolfini, C., Raffaelli, M., Rocchi, F., Bonati, M., Jong, G., De Hoog, M., & Der Anker, J. (2000). Survey of unlicensed and off-label drug use in paediatric wards in European countries. British Medical Journal, 320, 79-82.
13. Department of Health. (2000). Prescriptions Statistics Section Data (data supplied on file).
14. Emslie, G., Rush, A., Weinberg, W., Kowatch, R., Hughes, C., Carmody, T., & Rintelmann, J. (1997). A double-blind randomised placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
15. Essex, C., & Rylance, G. (1997). Children have rights to medicines. British Medical Journal, 315, 62.
16. Farmer, E., Stangl, D., Burns, B., Costello, E., & Angold, A. (1999). Use, persistence and intensity: Patterns of care for children's mental health across one year. Community Mental Health Journal, 35, 31-46.
17. Friman, P. (1995). Nocturnal enuresis in the child. In R. Ferber & M. Kryger (Eds.), Principles and Practice of Sleep Medicine in the Child. Philadelphia: W.B. Saunders Company.
18. Gelder, M.G., Lobez-Ibor, Jnr., J.J., & Andreasen, N. (Eds.) (2000). New Oxford Textbook of Psychiatry (pp. 1904-1910). Oxford: Oxford University Press.
19. Gillberg, C. (2000). Medication for children and adolescents. In M.G. Gelder, J.J. Lobez-Ibor Jnr., & N. Andreasen (Eds.), New Oxford Textbook of Psychiatry (pp. 1904-1910). Oxford: Oxford University Press.
20. Goldman-Rakic, C., & Brown, R. (1982). Post-natal development of monoamine content and synthesis in the cerebral cortex of Rhesus monkeys. Developmental Brain Research, 4, 339-349.
21. Graham, P., Turk, J., & Verhulst, F. (1999). Child Psychiatry: A Developmental Approach (3rd edn). Oxford: Oxford University Press.
22. Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995). Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis. British Medical Journal 310, 897-901.
23. Health Advisory Service. (1995). Thematic Review. Together We Stand. The Commissioning, Role and Management of Child and Adolescent Mental Health Services. London: HMSO.
24. Heyman, I. (1997). Children with obsessive-compulsive disorder. British Medical Journal, 315, 444.
25. Heyman, I., & Santosh, P. (2002). Drug treatment. In M. Rutter & E. Taylor (Eds.), Child and Adolescent Psychiatry (4th edn, pp. 998-1018). Oxford: Blackwell Scientific Publications.
26. Hill, P. (1998). Focus on evidence so far. In K. Dwivedi (Ed.), Evidence Based Mental Health Care. Conference Proceedings, March 9. Northampton Child & Adolescent Mental Health service.
27. Hill, P., & Taylor, E. (2001). An auditable protocol for treating attention-deficit/hyperactivity disorder. Archives of the Diseases of Childhood, 84, 404-409.
28. James, A. (1996). A survey of the prescribing practices of child and adolescent psychiatrists. Child Psychology and Psychiatry Review, 1, 94-97.
29. Jan, J., Freeman, R., & Fast, D. (1999). Melatonin treatment of sleep-wake cycle disorders of children and adolescents. Developmental Medicine and Child Neurology, 41, 491-500.
30. Jensen, P., Bhatara, V., Vitiello, B., Hoagwood, K., Fiel, M., & Burke, L. (1999). Psychoactive prescribing practices for the US children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 557-565.
31. Joughin, C., & Zwi, M. (1999). Focus on the Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder. London: Royal College of Psychiatrists.
32. Kaplan, C., & Hussain, S. (1995). Use of drugs in child and adolescent psychiatry. British Journal of Psychiatry, 166, 291-298.
33. Keen, D., Bramble, D., & Olurin-Lynch, J. (2000). Attention-deficit hyperactivity disorder: How much do we see? Child Psychology and Psychiatry Review, 5, 164-168.
34. Kewley, G. (1999). Risperidone in comorbid ADHD and ODD/CD (letter). Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1327-1328.
35. Knapp, M., & Henderson, J. (1999). Health economics perspectives and evaluation of child and adolescent mental health services. Current Opinion in Psychiatry, 12, 393-397.
36. Kutcher, S. (1997). Child and Adolescent Psychopharmacology. New York: WB Saunders.
37. Lowe-Ponsford, F., & Baldwin, D. (2000). Off-label prescription by psychiatrists. Psychiatric Bulletin, 24, 415-417.
38. McNicholas, F. (2001). Prescribing practices of child psychiatrists in the UK. Child Psychology and Psychiatry Review, 4, 166-171.
39. Montoliu, L., & Crawford, T. (in press). Prescribing practices of general practitioners to children with mental health problems. Child and Adolescent Mental Health.
40. National Institute of Clinical Excellence. (2000). Guidance on the Use of Methylphenidate (Ritalin, Equasym) for Attention Deficit/Hyperactivity Disorder (ADHD) in Childhood. London: HMSO.
41. Pfefferbaum, B., Overall, J., Boren, H., Frankel, L., Sullivan, M., & Johnson, K. (1987). Alprazolam in the treatment of anticipatory and acute situational anxiety in children with cancer. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 882-887.
42. Phillips, T., Salmon, G., & James, A.C. (in press). Prescribing practices in child and adolescent psychiatry: Change over time 1993-2000. Child and Adolescent Mental Health.
43. Pincus, H., Tanielian, T., Marcus, S., Olfson, M., Zarin, D., Thompson, J., & Zito, J. (1998). Prescribing trends in psychotropic medications in primary care, psychiatry and other medical specialties. Journal of the American Medical Association, 279, 526-531.
44. Prendergast, M. (1993). Drug treatment. In M.E. Garralda (Ed.), Managing Children with Psychiatric Problems. London: BMJ Publishing Group.
45. Prendergast, M. (2000). A pragmatic approach to medication. In C. Gillberg & G. O'Brien (Eds.), Clinics in Developmental Medicine No. 149: Developmental Disability and Behaviour (pp. 138-147). Cambridge: Mac Keith Press.
46. Richman, N. (1985). A double-blind drug trial of treatment in young children with waking problems. Journal of Child Psychology and Psychiatry, 26, 591-598.
47. Richman, N., Douglas, J., Hunt, H., Lansdown, R., & Levere, R. (1985). Behavioural methods in the treatment of sleep disorders: A pilot study. Journal of Child Psychology and Psychiatry, 26, 581-590.
48. Riddle, M.A., Kastelic, E.A., & Frosch, E. (2000). Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry, 42, 73-79.
49. Royal College of General Practitioners. (2000). The Joint Committee on Postgraduate Training for General Practice: A Guide to Certification. London: JCPTGP.
50. Royal College of Psychiatrists (March 1998). Higher Specialist Training Handbook. Occasional Paper 43. London: Royal College of Psychiatrists.
51. Rutter, M., & Taylor, E. (Eds.) (2002). Child and Adolescent Psychiatry: Modern Approaches (4th edn). Oxford: Blackwell Scientific Publications.
52. Rutter, M., Tizard, J., & Whitemore, K. (1970). Education, Health and Behaviour, London: Longman.
53. Rylance, G. (1979). Therapeutic underprivileged. Developmental Medicine and Child Neurology, 21, 399-400.
54. Santosh, P., & Baird, G. (1999). Psychopharmacology in children and adults with intellectual disability. Lancet, 354, 231-240.
55. Secretary of State for Health. (1998). Our Healthier Nation. A Contract for Health. London: The Stationery Office Limited.
56. Simonoff, E., & Stores, G. (1987). Controlled trial of trimeprazine tartrate for night waking. Archives of Diseases in Childhood, 62, 253-257.
57. Slaveska, K., Hollis, C., & Bramble, D. (1998). Use of antipsychotics by child and adolescent psychiatrists. Psychiatric Bulletin, 22, 685-687.
58. Sproson, E., Chantrey, J., Hollis, C., Marsden, C., & Fone, K. (2001). Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young rats. Journal of Psychopharmacology, 15, 67-75.
59. Stores, G. (1990). Sleep disorders in children. British Medical Journal, 301, 351-352.
60. Stores, G., & Crawford, C. (1998). Medical student education in sleep and its disorders. Journal of the Royal College of Physicians, 32, 149-153.
61. Stores, G. (1999). Recognition and management of narcolepsy. Archives of Disease in Childhood, 81, 519-524.
62. Taylor, E. (1994). Physical treatments. In M. Rutter., E. Taylor, & L. Hersov (Eds.), Child and Adolescent Psychiatry: Modern Approaches (3rd edn). Oxford: Blackwell Scientific Publications.
63. Weeramanthri, T., & Keaney, F. (2000). What do inner city practitioners want from child and adolescent mental health services? Psychiatric Bulletin, 24, 256-260.
64. WHO. (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organisation.